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Surgical stress causes changes in the composition of
white blood cells (WBCs). Ketorolac is believed to have
analgesic effects and to reduce the stress response and may
therefore improve postoperative outcomes. The aim of this
study was to assess the effect of preoperative ketorolac on
the WBC subsets in patients who had laparoscopic surgery
for endometriosis. Fifty patients who had laparoscopic sur-
gery for endometriosis were randomly assigned to one of
two groups: the ketorolac group (n = 25) received ketorolac
0.5 mg/kg before the induction of anesthesia, and the control
group (n = 25) received saline. White cell count, differential,
and pathology studies were done immediately after surgery,
on postoperative day 1, and on postoperative day 3. We
compared the baseline values within and between the two
groups. We also assessed postoperative pain and side
effects. The time that elapsed before the first patient request
for analgesia, total meperidine dose and VAS (Visual
Analog Scale) for postoperative pain were significantly
lower in the ketorolac group than in the control group.
Compared to the pre- surgical values, there was an increase
in total WBC count and percentage of neutrophils, but a
decrease in percentages of lymphocytes, monocytes, eosino-
phils, basophils, and leucocytes. Total WBC count, neutro-
phils, monocytes, eosinophils and leucocytes showed signi-
ficant differences between the two groups. The incidences
of postoperative side effects, such as nausea, dizziness,
headache, and shoulder pain were not different between the
groups. Preoperative ketorolac reduced postoperative pain
and influenced the WBC response in laparoscopic surgery
for endometriosis.
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INTRODUCTION
Endometriosis lesions can be removed during
laparoscopy by surgical excision with scissor and
bipolar coagulation. This can cause broad intra-
peritoneal thermal damage. Some evidence shows
that the release of the excitatory amino-acid, nitric
oxide, and prostaglandin E2 (PGE2) play a critical
role in the development of peripheral tactile and
thermal hypersensitivity in models of pain due to
inflammation.
1,2 Major surgery or trauma is fol-
lowed by changes in the composition of white
blood cells (WBCs). These changes are charac-
terized as lymphopenia and polymorphonuclear
leucocytosis.
3,4 The stress response that is initiated
in major surgeries causes a release of cortisol and
also affects leukocyte numbers.
5
The synthesis of PGE2 can be controlled by a
cyclooxygenase (COX) inhibitor such as ketorolac
tromethamine.
6 Ketorolac is an injectable nonste-
roidal anti-inflammatory drug (NSAID) that is
thought to have analgesic effects and to reduce
the stress response and may therefore improve
postoperative outcomes.
7
We tested the hypothesis that the admin-
istration of ketorolac before skin incision reduces
postoperative pain and improves blood cell
responses in women undergoing laparoscopic
surgery for endometriosis.
MATERIALS AND METHODS
This was a randomized, placebo-controlled,
double-blind study. After Institutional Review
Board approval, written informed consent was
obtained from a total of 50 patients scheduled for
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elective laparoscopic surgery for endometriosis
grade III or IV.
8 We excluded patients with al-
lergies to NSAIDs or opioids, an active ulcer
within 6 months, a history of bleeding problems,
recent anticoagulant use, and patients currently
pregnant, breast-feeding, or receiving steroids. We
also excluded patients with ASA physical status of
III or greater, and patients with significant coex-
isting hepatic, renal, neurological, pulmonary, or
cardiac disease.
Patients were randomly assigned to one of two
groups. Randomization was carried out by means
of a computerized random-numbers table. The
ketorolac group (n = 25) received IV ketorolac 0.5
mg/kg, and the placebo group (n = 25) received
saline of the same volume. The medications were
prepared by a nurse who was not involved in the
procedure. The surgeon, anesthesiologist and the
patient were all blinded to the identity of the
medication used.
No premedication was given. General anes-
thesia consisted of propofol (2 mg/kg), fentanyl
(0.05 mg), rocuronium (0.5 mg/kg) for induction,
and rocuronium and enflurane in nitrous oxide-
oxygen for maintenance.
Venous blood samples were collected four times
throughout the study period (30 minutes before
induction as a baseline, immediately after surgery,
1 day postoperatively, and 3 days postopera-
tively). The changes of white cell count and the
compositions immediately after surgery, on post-
operative day 1 and on postoperative day 3 were
compared to the baseline values within the groups
and these values were compared between the
groups. Hematological measurements were per-
formed using an ADVIA 120 (Bayer Co. Dublin,
Ireland).
Postoperative pain was assessed using a 100
mm visual analog scale (VAS, 0 = no pain; 100 =
worst pain possible) at 2, 6, 12, and 24 hours after
surgery. Total analgesic doses during 72 hours
were recorded. The time elapsed between the end
of surgery and the first analgesic request (first
analgesic time) was also recorded. Postoperative
side effects and treatments were observed. An
independent observer who was blinded to the
study protocol collected the data in the recovery
room.
Power analysis was performed using an -value α
of 0.05 and a power of 0.9 to determine the sample
size sufficient for establishing a significant dif-
ference in peripheral blood response based on the
results of the preliminary study. A sample con-
sisting of at least 24 patients per group was neces-
sary.
Demographic and clinical data of the two
groups were compared using the Student's t-test.
Because neither the peripheral blood cell count
nor the analgesic dose was distributed normally,
the Mann-Whitney test was used to compare the
two groups during the same time period. Within
the groups, comparisons of the peripheral blood
cell levels to the baseline values were performed
using the repeated measures ANOVA on ranks
and the Dunnet method. Chi-square and Fisher's
exact tests examined group differences for adverse
side effects. A p value less than 0.05 was consid-
ered to be significant.
RESULTS
Between the two groups, no significant differ-
ences in age, weight, height, or clinical data, such
as duration of anesthesia, blood loss, and amount
of total fluid administered were found (Table 1).
The total meperidine dose (mg) required to
control postoperative pain was 128.5 ± 91.2 in the
control group and 74.5 ± 42.1 in the ketorolac
group (p< 0.05). Significantly more patients in the
control group (17/25, 68%) required postoperative
analgesics compared to the ketorolac group (7/25,
28%). The first analgesic request time was 69.4 ±
11.9 (min) in the control group and 226.3 ± 36.3
(min) in the ketorolac group (p< 0.05). The VAS
values for pain at 2, 6, and 12 hours after surgery
were significantly lower in the ketorolac group
than in the control group (Fig. 1).
Total white cell count including neutrophils
and monocytes showed significant differences
between the two groups at 3 days after surgery.
Eosinophil percentages were significantly higher
in the ketorolac group compared to the control
group at day 1 and day 3 after surgery (Table 2).
Both groups showed a significant drop in post-
operative red blood cell, hemoglobin, and hema-
tocrit levels compared with baseline values (Table
3). There are no significant red blood cell patternJeong-Yeon Hong
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Table 1. Demographic and Clinical Data
Control group (n = 25) Ketorolac group (n = 25)
Age (yrs) 33.2 ± 6.6 32.9 ± 5.2
Weight (kg) 56.7 ± 7.7 54.3 ± 4.5
Height (cm) 161.2 ± 5.2 160.8 ± 4.1
Duration of anesthesia (min) 90.6 ± 20.4 83.5 ± 23.8
Total fluid (mL) 923 ± 122 1038 ± 185
Estimated blood loss (mL) 221 ± 46 205 ± 55
Urine output (mL) 155 ± 70 145 ± 55
Data are mean ± SD.
There are no significant differences between the two groups.
Table 2. Changes in White Blood Cell Responses
Parameters Baseline Postop. (Immediate) Postop. (1 day) Postop. (3 days)
WBC (10
3/ L) μ
Control group (n=25) 6.3 ± 2.3 8.0 ± 2.5 8.4 ± 2.8 6.1 ± 1.5
Ketorolac group (n=25) 5.9 ± 1.8 7.0 ± 2.1 8.2 ± 1.9 5.2 ± 1.2*
Neutrophils (%)
Control group 60.0 ± 18.4 60.2 ± 14.1 76.1 ± 8.2 56.9 ± 7.8
Ketorolac group 55.1 ± 12.3 59.7 ± 15.2 73.1 ± 6.9 50.0 ± 8.3*
Lymphocytes (%)
Control group 34.3 ± 7.2 32.8 ± 12.3 20.6 ± 6.8 33.0 ± 7.3
Ketorolac group 33.6 ± 9.3 32.5 ± 13.5 18.8 ± 5.1 35.3 ± 7.4
Monocytes (%)
Control group 4. ± 1.3 3.5 ± 1.3 4.9 ± 1.5 4.7 ± 1.1
Ketorolac group 4.7 ± 1.3 3.6 ± 1.2 5.0 ± 1.4 5.5 ± 1.6*
Eosinophils (%)
Control group 2.0 ± 1.3 1.0 ± 0.8 0.8 ± 0.6 3.0 ± 1.6
Ketorolac group 2.6 ± 1.8 1.6 ± 1.3 1.6 ±
1.0* 4.3 ± 1.1*
Basophils (%)
Control group 0.8 ± 0.5 0.6 ± 0.3 0.4 ± 0.1 0.6 ± 0.2
Ketorolac group 0.7 ± 0.3 0.6 ± 0.2 0.4 ± 0.2 0.7 ± 0.2
Data are mean ± SD.
Total white cell count, neutrophil, and monocyte showed significant differences between the two groups at 3 days after surgery.
Percentages of Eosinophils were significantly higher in the ketorolac group compared to the control group at day 1 and day 3 after
surgery.
*p< 0.05 compared to the control group.
p< 0.05 compared to the baseline values.Effect of Ketorolac on WBC and Pain
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differences between the two groups.
The incidences of postoperative side effects,
such as nausea, dizziness, headache, and shoulder
pain were essentially the same for both groups.
There were no serious side effects such as oozing
or bleeding which are occasionally observed as a
postoperative complication of ketorolac use.
DISCUSSION
Preemptive analgesia is currently being used for
the management of postoperative pain and is no
longer actively researched. However, the clinical
efficacy of NSAIDs is controversial. Norman et al.
reported that intravenous ketorolac appears to
have preemptive analgesic effects in patients
undergoing ankle fracture repair.
9 However, a
study by Cabell did not demonstrate preemptive
analgesic effects in laparoscopic gynecologic sur-
gery.
10 Preemptive analgesic effects are difficult to
show in human experiments because of the dif-
ferences in surgical procedures, dose, route, and
timing of administration. Our study supports the
finding that the preoperative use of 30 mg of
ketorolac for endometriosis surgery that causes
broad thermal tissue damage provides not only
opioid-sparing, but also preemptive analgesic
effects. Evidence regarding the preemptive an-
algesic effects of ketorolac requires controlled
studies comparing effects before and after sur-
gery. However, our report did not follow such a
design. In our study, postoperative pain scores
were lessened even beyond the 12-hour duration
of ketorolac which suggested preemptive effects.
Our findings are consistent with previous studies
in which preoperative administration of an
NSAID decreased postoperative opioid require-
ments following laparoscopic surgery.
11-13
One concern with the use of ketorolac has been
the possibility of NSAID-specific adverse side
effects such as oozing or oliguria. FDA guidelines
for intravenous ketorolac use suggest using a dose
of 30 mg to minimize these effects. In our study,
no adverse events related to the use of ketorolac
30 mg were observed. There were no significant
differences between the two groups in the occur-
rence of postoperative side effects.
In addition to pain management, ketorolac is
thought to help maintain immune homeostasis.
Leukocytes are the major cellular components of
the inflammatory and immune responses which
also include neutrophils, lymphocytes, monocytes,
eosinophils, and basophils. Major surgical stress
causes lymphopenia with leucocytosis.
3,4 The
increased release of cortisol that accompanies the
stress response or the exogenous administration of
adrenaline as is done in major surgeries, can also
Table 3. Changes in Red Blood Cell, Hemoglobin, and Hematocrit Levels
Parameters Baseline Postop. (Immediate) Postop. (1 day) Postop. (3 days)
RBC (10
6/ L) μ
Control group 4.3 ± 0.3 3.9 ± 0.4* 3.7 ± 0.3* 3.8 ± 0.5*
Ketorolac group 4.3 ± 0.3 3.9 ± 0.3* 3.7 ± 0.3* 3.8 ± 0.4*
Hg (g/dL)
Control group 12.3 ± 0.9 11.4 ± 0.8* 10.9 ± 0.9* 10.9 ± 1.2*
Ketorolac group 12.4 ± 1.0 11.5 ± 0.8* 10.9 ± 0.8* 11.0 ± 0.8*
Hct (%)
Control group 37.0 ± 2.1 33.8 ± 2.2* 32.2 ± 2.5* 32.5 ± 3.8*
Ketorolac group 37.0 ± 2.4 34.1 ± 2.2* 32.4 ± 2.6* 33.1 ± 2.7*
Data are mean ± SD.
Postoperative red blood cell, hemoglobin, and hematocrit levels decreased significantly compared with baseline values in the two
groups. There are no significant differences between the two groups.
*p < 0.05 compared to the baseline values.Jeong-Yeon Hong
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affect leukocyte numbers.
5 In the two groups of
our study, there was a significant increase in
white cell and neutrophil counts, but a decrease
in lymphocytes, monocytes, eosinophils, and baso-
phils compared to the baseline. The ketorolac
group, however, showed more effective recovery
in these variables in the postoperative period than
the control group. Changes in circulating leuko-
cyte numbers may be caused by an absolute
change in total leukocyte count or an alteration in
the fraction of leukocytes. An increase in the
number of blood neutrophils is called neutro-
philia. The granules of neutrophils are readily
released extracellularly, and their mobilization is
believed to be important in modulating inflamma-
tion. In both groups of our study, neutrophil
counts increased 24 hours after surgery and later
returned to baseline values. However, at 3 days
after surgery, the percentage of neutrophils was
significantly lower in the ketorolac group than in
the control group.
Monocytes are important secretory cells that,
through their receptors and secretory products,
participate in many complex immunologic and
inflammatory processes not attributed to neutro-
phils. Eosinophils and neutrophils share similar
morphology, lysosomal constituents, chemotactic
responses, phagocytic capacity, and oxidative
metabolism. Eosinophenia occurs during a stress
response, such as acute infection, or the admini-
stration of corticosteroids.
14 The mechanism of
eosinopenia is unknown and there is no known
adverse clinical effect of eosinopenia. In our
results, it was observed that the percentages of
monocytes and eosinophils decreased significantly
following surgery. In the ketorolac group, mono-
cytes increased at 3 days after surgery and eosino-
phils were found to be increased at days 1 and 3
after surgery. These levels were significantly
higher than the control group.
Lymphocyte is a primary mediator in humoral
and cellular immune responses. The lymphocyte
levels did not show significant differences
between the two groups, although there were
decreases in lymphocytes at postoperative day 1
compared to the baselines in the both groups. In
the late postoperative period, there were signi-
ficant decreases of lymphocyte and neutrophil
levels in our study. Further studies are required
to explain these findings. The variations of WBC
responses may be due to the differences in sur-
gical procedures, subjects, or study designs.
15-17
Our results confirmed that ketorolac can posi-
tively influence leukocyte distribution after sur-
gery, although the clinical efficacy is unclear.
Several factors are likely to be involved in medi-
ating the white cell responses to surgery. Physio-
logic cortisol and catecholamines can influence the
distribution of leukocytes.
18,19 Unfortunately, we
did not monitor hormone levels such as cortisol,
prolactin, or catecholamines, or neutrophil func-
tion, subtypes of lymphocytes and leukocytes,
CRP, interleukin-6, or plasma ketorolac concentra-
tion. These may be considered limitations of this
study. The above laboratory findings are more
reliable than peripheral WBC responses, but are
more complicated, time consuming, and clinically
limited.
In summary, this study demonstrated greater
improvement in postoperative pain scores and
reduced requirements for meperidine following
the administration of preoperative ketorolac com-
pared to the control. Postoperative leukocytosis,
neutrophilia, and a decrease in monocytes and
eosinophils after surgery were affected by pre-
operative intravenous ketorolac.
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